Evan pepper (Talk | contribs) |
Evan pepper (Talk | contribs) |
||
Line 91: | Line 91: | ||
} | } | ||
− | @media (min-width: 768px) { | + | /*@media (min-width: 768px) { |
.navbar-collapse.collapse { | .navbar-collapse.collapse { | ||
display: none !important; | display: none !important; | ||
} | } | ||
− | } | + | }*/ |
@media (max-width: 1086px) { | @media (max-width: 1086px) { |
Revision as of 19:03, 11 September 2017
![](https://static.igem.org/mediawiki/2017/f/f9/3synechobuddies.png)
Project Description
We are using the cyanobacteria genus Synechococcus as a model for the FDA-approved Arthrospira platensis, commonly known as Spirulina. By focusing on an edible cyanobacteria, we hope to generate an easily consumable, photosynthetic culture of vitamin or pharmaceutical synthesizers.
Of the three non-opioid pain reducers on the World Health Organization’s (WHO) list of essential medicines, we have decided to pursue acetaminophen, the active ingredient in Tylenol, do to the feasibility of recreating the metabolic pathway in a cyanobacteria. With respect to vitamins, we aim to produce human usable vitamin B12 because it is one of the few vitamins that A. platensis does not adequately produce.
Click on an icon below to learn more about our project!